Biotech

All Articles

Novo inks $600M NanoVation deal to study hereditary drugs ex-liver

.Novo Nordisk is actually proceeding its own push into genetic medicines, consenting to compensate N...

Innovent links cytokine to intestines cancer cells actions

.Innovent Biologics has actually made the instance that its own checkpoint inhibitor-cytokine fusion...

Merck, Daiichi ADC attacks target in phase 3 lung cancer research study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina grows artificial intelligence focus with collab to decide on cancer cells aim ats

.5 months after Rakovina Therapeutics pivoted towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism drug smash hits in phase 3, endangers BioMarin

.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, reporting period 3 growth d...

Despite ph. 3 skip, Alkeus views pathway ahead of time for eye disease possession

.Though Alkeus Pharmaceuticals' dental eye ailment possession neglected to considerably minimize geo...

Kairos goes public with $6M IPO to finance trials of cancer cells medicine

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually very easy to skip a sm...

Vaccine and Keytruda combo successful in squamous tissue carcinoma

.Immune gate inhibitors are actually the superheroes of cancer cells treatment. Medicines like Brist...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Regeneron's Opdualag opponent presents 57% reaction cost

.Regeneron is back along with long-lasting consequence for its own LAG-3 inhibitor and also PD-1 inh...